Balyasny Asset Management’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
+512,249
New +$16M 0.02% 955
2025
Q4
Sell
-45,822
Closed -$3.35M 3192
2025
Q3
$3.35M Buy
+45,822
New +$2.99M ﹤0.01% 1569
2025
Q1
Sell
-84,189
Closed -$4.49M 2886
2024
Q4
$4.49M Buy
+84,189
New +$4.12M 0.01% 1332
2024
Q1
Sell
-262,162
Closed -$7.35M 2732
2023
Q4
$7.35M Sell
262,162
-341,867
-57% -$8.08M 0.01% 978
2023
Q3
$12.8M Buy
604,029
+85,837
+17% +$2.34M 0.03% 749
2023
Q2
$17.6M Buy
+518,192
New +$17.3M 0.04% 578
2022
Q2
Sell
-29,523
Closed -$1.54M 2844
2022
Q1
$1.54M Buy
+29,523
New +$1.49M ﹤0.01% 1470
2021
Q3
Sell
-104,890
Closed -$6.11M 2053
2021
Q2
$6.11M Buy
+104,890
New +$5.89M 0.03% 651

Other funds holding DOCS

Balyasny Asset Management's DOCS Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Doximity (DOCS) in Q1 2026: 512,249 shares worth $11.9M. The stake represents 0.02% of the portfolio and ranks #955 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in DOCS as recently as Q3 2025.

Balyasny Asset Management first reported a position in DOCS in Q2 2021 and has held it in 8 quarters since. The position peaked at $17.6M in Q2 2023. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Balyasny Asset Management held 512,249 shares of Doximity worth $11.9M as of Q1 2026.
  • Doximity was a new Balyasny Asset Management position in Q1 2026.
  • Doximity made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #955 holding.
  • Balyasny Asset Management first reported a position in Doximity in Q2 2021 and has held it in 8 quarters since.
  • Balyasny Asset Management's Doximity position peaked at $17.6M in Q2 2023.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.